Condition
Low Rectal Cancer
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (2)
Trial Status
Recruiting2
Unknown2
Enrolling By Invitation1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07463261Not ApplicableRecruiting
REsults of LOw Anterior Resections With or Without Preventive Stoma in Nonemergency Department
NCT07346534Not ApplicableEnrolling By InvitationPrimary
Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study
NCT05972655Phase 2RecruitingPrimary
Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer
NCT02488577Not ApplicableUnknownPrimary
Outcomes of TAMIS-Total Mesorectal Excision Versus Transanal Loco-regional Excision for T2 Low Rectal Cancer
NCT02468362Phase 2UnknownPrimary
Long Term Outcomes After Laparoscopic Intersphincteric Resection With Total Mesorectal Excision for Low Rectal Cancer.
Showing all 5 trials